ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Est. Return 169.78%
This Quarter Est. Return
1 Year Est. Return
+169.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$71.6M
AUM Growth
-$14.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$2.62M
2
+$1.77M
3
+$1.12M
4
AKRO icon
Akero Therapeutics
AKRO
+$1.06M
5
TERN icon
Terns Pharmaceuticals
TERN
+$516K

Top Sells

1
+$6.94M
2
+$5.22M
3
+$2.29M
4
MRK icon
Merck
MRK
+$2.06M
5
OCUL icon
Ocular Therapeutix
OCUL
+$1.9M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPP
26
Rapport Therapeutics
RAPP
$1.15B
$227K 0.32%
20,000
+3,600
ARTV
27
Artiva Biotherapeutics
ARTV
$147M
$68.6K 0.1%
45,456
NUVB.WS icon
28
Nuvation Bio Inc Warrants
NUVB.WS
$64.4M
$24.5K 0.03%
90,832
ELVN icon
29
Enliven Therapeutics
ELVN
$1.27B
– –
-265,269
EWTX icon
30
Edgewise Therapeutics
EWTX
$1.59B
– –
-85,454
FBRX icon
31
Forte Biosciences
FBRX
$150M
– –
-18,469
GILD icon
32
Gilead Sciences
GILD
$152B
– –
-9,298
MREO
33
Mereo BioPharma
MREO
$326M
– –
-791,815
MRK icon
34
Merck
MRK
$212B
– –
-22,994
RCKT icon
35
Rocket Pharmaceuticals
RCKT
$400M
– –
-83,350
VERV
36
DELISTED
Verve Therapeutics
VERV
– –
-162,724
1
2